ODT
Odonate Therapeutics, Inc. Common Stock
Delisted
ODT was delisted on the 14th of January, 2022.
50 hedge funds and large institutions have $32.7M invested in Odonate Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
66% less capital invested
Capital invested by funds: $95M → $32.7M (-$62.2M)
88% less call options, than puts
Call options by funds: $7K | Put options by funds: $56K
Holders
50
Holding in Top 10
1
Calls
$7K
Puts
$56K
Top Buyers
| 1 | +$404K | |
| 2 | +$351K | |
| 3 | +$317K | |
| 4 |
D.E. Shaw & Co
New York
|
+$190K |
| 5 |
Renaissance Technologies
New York
|
+$186K |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$3.71M | |
| 3 | -$1.89M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.01M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$675K |